| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-aminoacyl-tRNA binding | 4.05e-05 | 3 | 74 | 2 | GO:1904678 | |
| GeneOntologyMolecularFunction | SUMO ligase activity | 5.32e-05 | 20 | 74 | 3 | GO:0061665 | |
| GeneOntologyMolecularFunction | mRNA cap binding complex binding | 8.09e-05 | 4 | 74 | 2 | GO:0140262 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 3.19e-04 | 36 | 74 | 3 | GO:0019789 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 6.70e-07 | 20 | 73 | 4 | GO:0006607 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 3.52e-06 | 9 | 73 | 3 | GO:0033133 | |
| GeneOntologyBiologicalProcess | nuclear export | 4.12e-06 | 185 | 73 | 7 | GO:0051168 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 5.01e-06 | 10 | 73 | 3 | GO:1903301 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 1.19e-05 | 13 | 73 | 3 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 1.51e-05 | 14 | 73 | 3 | GO:1903299 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 5.27e-05 | 187 | 73 | 6 | GO:0007156 | |
| GeneOntologyBiologicalProcess | nuclear transport | 5.62e-05 | 378 | 73 | 8 | GO:0051169 | |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | 5.62e-05 | 378 | 73 | 8 | GO:0006913 | |
| GeneOntologyBiologicalProcess | negative regulation of synaptic transmission | 1.86e-04 | 80 | 73 | 4 | GO:0050805 | |
| GeneOntologyBiologicalProcess | cell-cell junction assembly | 3.16e-04 | 167 | 73 | 5 | GO:0007043 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 3.28e-04 | 38 | 73 | 3 | GO:0000413 | |
| GeneOntologyBiologicalProcess | regulation of mitotic metaphase/anaphase transition | 3.60e-04 | 95 | 73 | 4 | GO:0030071 | |
| GeneOntologyBiologicalProcess | regulation of metaphase/anaphase transition of cell cycle | 4.06e-04 | 98 | 73 | 4 | GO:1902099 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of mitotic cell cycle | 4.38e-04 | 100 | 73 | 4 | GO:0007091 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 2.45e-06 | 8 | 75 | 3 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 5.23e-06 | 10 | 75 | 3 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 1.57e-05 | 14 | 75 | 3 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 3.48e-05 | 18 | 75 | 3 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 4.84e-05 | 20 | 75 | 3 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 5.63e-05 | 21 | 75 | 3 | GO:0106068 | |
| GeneOntologyCellularComponent | glutamatergic synapse | PRUNE2 ANO2 GRID2IP CALD1 PPP1R9A APBA1 APC DGCR8 RIMS2 CDH8 PCDH17 | 1.52e-04 | 817 | 75 | 11 | GO:0098978 |
| GeneOntologyCellularComponent | catenin complex | 2.04e-04 | 32 | 75 | 3 | GO:0016342 | |
| GeneOntologyCellularComponent | synaptic membrane | 2.34e-04 | 583 | 75 | 9 | GO:0097060 | |
| GeneOntologyCellularComponent | postsynapse | GRID2IP ANK2 CALD1 PPP1R9A APBA1 APC RPS17 CLMP DGCR8 PALMD GRM6 PCDH17 | 2.55e-04 | 1018 | 75 | 12 | GO:0098794 |
| GeneOntologyCellularComponent | cell-cell junction | 2.59e-04 | 591 | 75 | 9 | GO:0005911 | |
| GeneOntologyCellularComponent | nuclear pore | 4.80e-04 | 101 | 75 | 4 | GO:0005643 | |
| GeneOntologyCellularComponent | CMG complex | 6.84e-04 | 11 | 75 | 2 | GO:0071162 | |
| GeneOntologyCellularComponent | anchoring junction | 6.88e-04 | 976 | 75 | 11 | GO:0070161 | |
| GeneOntologyCellularComponent | DNA replication preinitiation complex | 9.66e-04 | 13 | 75 | 2 | GO:0031261 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 1.20e-03 | 129 | 75 | 4 | GO:0030863 | |
| GeneOntologyCellularComponent | nBAF complex | 1.48e-03 | 16 | 75 | 2 | GO:0071565 | |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 1.50e-03 | 137 | 75 | 4 | GO:0019897 | |
| GeneOntologyCellularComponent | cell tip | 1.67e-03 | 17 | 75 | 2 | GO:0051286 | |
| GeneOntologyCellularComponent | cell cortex | 2.16e-03 | 371 | 75 | 6 | GO:0005938 | |
| GeneOntologyCellularComponent | cell pole | 2.31e-03 | 20 | 75 | 2 | GO:0060187 | |
| MousePheno | aneuploidy | 7.75e-06 | 61 | 63 | 5 | MP:0004024 | |
| MousePheno | abnormal chromosome number | 4.16e-05 | 86 | 63 | 5 | MP:0004023 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 4.69e-05 | 16 | 63 | 3 | MP:0003701 | |
| MousePheno | failure of blastocyst to hatch from the zona pellucida | 1.18e-04 | 107 | 63 | 5 | MP:0003694 | |
| MousePheno | abnormal blastocyst hatching | 1.53e-04 | 113 | 63 | 5 | MP:0003693 | |
| MousePheno | abnormal cell nucleus morphology | 1.75e-04 | 184 | 63 | 6 | MP:0003111 | |
| MousePheno | abnormal rod electrophysiology | 1.95e-04 | 119 | 63 | 5 | MP:0004021 | |
| MousePheno | abnormal morula morphology | 2.11e-04 | 26 | 63 | 3 | MP:0012058 | |
| MousePheno | abnormal chromosome morphology | 2.54e-04 | 126 | 63 | 5 | MP:0003702 | |
| MousePheno | increased hepatocellular carcinoma incidence | 2.75e-04 | 70 | 63 | 4 | MP:0003331 | |
| MousePheno | decreased tumor latency | 3.25e-04 | 30 | 63 | 3 | MP:0010308 | |
| MousePheno | failure of blastocyst formation | 3.58e-04 | 31 | 63 | 3 | MP:0012129 | |
| MousePheno | increased incidence of tumors by chemical induction | 4.27e-04 | 141 | 63 | 5 | MP:0004499 | |
| MousePheno | abnormal tumor latency | 4.73e-04 | 34 | 63 | 3 | MP:0010307 | |
| Domain | Grip | 6.94e-08 | 11 | 73 | 4 | SM00755 | |
| Domain | GRIP | 6.94e-08 | 11 | 73 | 4 | PF01465 | |
| Domain | Ran_BP1 | 1.04e-07 | 12 | 73 | 4 | PF00638 | |
| Domain | GRIP_dom | 1.04e-07 | 12 | 73 | 4 | IPR000237 | |
| Domain | GRIP | 1.04e-07 | 12 | 73 | 4 | PS50913 | |
| Domain | RANBD1 | 1.04e-07 | 12 | 73 | 4 | PS50196 | |
| Domain | RanBD | 1.50e-07 | 13 | 73 | 4 | SM00160 | |
| Domain | Ran_bind_dom | 1.50e-07 | 13 | 73 | 4 | IPR000156 | |
| Domain | GCC2_Rab_bind | 1.98e-06 | 7 | 73 | 3 | IPR032023 | |
| Domain | Rab_bind | 1.98e-06 | 7 | 73 | 3 | PF16704 | |
| Domain | Cadherin_CS | 4.26e-06 | 109 | 73 | 6 | IPR020894 | |
| Domain | CADHERIN_1 | 5.25e-06 | 113 | 73 | 6 | PS00232 | |
| Domain | Cadherin | 5.25e-06 | 113 | 73 | 6 | PF00028 | |
| Domain | CADHERIN_2 | 5.53e-06 | 114 | 73 | 6 | PS50268 | |
| Domain | - | 5.53e-06 | 114 | 73 | 6 | 2.60.40.60 | |
| Domain | CA | 5.81e-06 | 115 | 73 | 6 | SM00112 | |
| Domain | Cadherin-like | 6.11e-06 | 116 | 73 | 6 | IPR015919 | |
| Domain | - | 6.74e-06 | 10 | 73 | 3 | 1.10.220.60 | |
| Domain | Cadherin | 6.75e-06 | 118 | 73 | 6 | IPR002126 | |
| Domain | PDZ | 2.27e-04 | 141 | 73 | 5 | PF00595 | |
| Domain | PH_dom-like | 2.52e-04 | 426 | 73 | 8 | IPR011993 | |
| Domain | PDZ | 2.84e-04 | 148 | 73 | 5 | SM00228 | |
| Domain | - | 3.03e-04 | 150 | 73 | 5 | 2.30.42.10 | |
| Domain | TPR-contain_dom | 3.03e-04 | 150 | 73 | 5 | IPR013026 | |
| Domain | PDZ | 3.12e-04 | 151 | 73 | 5 | PS50106 | |
| Domain | PDZ | 3.22e-04 | 152 | 73 | 5 | IPR001478 | |
| Domain | TPR_REGION | 4.69e-04 | 165 | 73 | 5 | PS50293 | |
| Domain | TPR | 4.69e-04 | 165 | 73 | 5 | PS50005 | |
| Domain | TPR | 1.64e-03 | 129 | 73 | 4 | SM00028 | |
| Domain | TPR_repeat | 1.83e-03 | 133 | 73 | 4 | IPR019734 | |
| Domain | TPR-like_helical_dom | 2.18e-03 | 233 | 73 | 5 | IPR011990 | |
| Domain | - | 4.24e-03 | 391 | 73 | 6 | 2.30.29.30 | |
| Domain | Cadherin_cytoplasmic-dom | 4.26e-03 | 25 | 73 | 2 | IPR000233 | |
| Domain | Cadherin_C | 4.26e-03 | 25 | 73 | 2 | PF01049 | |
| Domain | TPR_1 | 5.28e-03 | 90 | 73 | 3 | PF00515 | |
| Domain | TPR_1 | 5.28e-03 | 90 | 73 | 3 | IPR001440 | |
| Domain | Catenin_binding_dom | 5.71e-03 | 29 | 73 | 2 | IPR027397 | |
| Domain | - | 5.71e-03 | 29 | 73 | 2 | 4.10.900.10 | |
| Domain | MAGE | 7.80e-03 | 34 | 73 | 2 | SM01373 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 2.92e-05 | 18 | 48 | 3 | MM1549 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 3.35e-04 | 40 | 48 | 3 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 3.61e-04 | 41 | 48 | 3 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 3.87e-04 | 42 | 48 | 3 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 4.16e-04 | 43 | 48 | 3 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 5.41e-04 | 47 | 48 | 3 | MM14939 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 6.12e-04 | 49 | 48 | 3 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 6.49e-04 | 50 | 48 | 3 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 6.88e-04 | 51 | 48 | 3 | MM15151 | |
| Pathway | REACTOME_UNWINDING_OF_DNA | 7.33e-04 | 12 | 48 | 2 | M3656 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 8.58e-04 | 55 | 48 | 3 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 1.00e-03 | 58 | 48 | 3 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 1.00e-03 | 58 | 48 | 3 | MM14736 | |
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 6.95e-10 | 7 | 75 | 4 | 15710750 | |
| Pubmed | 3.35e-07 | 7 | 75 | 3 | 21205196 | ||
| Pubmed | 3.35e-07 | 7 | 75 | 3 | 18949001 | ||
| Pubmed | 3.35e-07 | 7 | 75 | 3 | 25187515 | ||
| Pubmed | 3.35e-07 | 7 | 75 | 3 | 9037092 | ||
| Pubmed | 3.35e-07 | 7 | 75 | 3 | 8603673 | ||
| Pubmed | 3.35e-07 | 7 | 75 | 3 | 26632511 | ||
| Pubmed | 3.35e-07 | 7 | 75 | 3 | 24403063 | ||
| Pubmed | 3.35e-07 | 7 | 75 | 3 | 23818861 | ||
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 3.35e-07 | 7 | 75 | 3 | 11353387 | |
| Pubmed | 3.35e-07 | 7 | 75 | 3 | 30944974 | ||
| Pubmed | 3.35e-07 | 7 | 75 | 3 | 38838144 | ||
| Pubmed | 3.35e-07 | 7 | 75 | 3 | 23536549 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 3.35e-07 | 7 | 75 | 3 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 3.35e-07 | 7 | 75 | 3 | 17372272 | |
| Pubmed | 3.35e-07 | 7 | 75 | 3 | 38657106 | ||
| Pubmed | 3.35e-07 | 7 | 75 | 3 | 12191015 | ||
| Pubmed | 3.35e-07 | 7 | 75 | 3 | 22821000 | ||
| Pubmed | 3.35e-07 | 7 | 75 | 3 | 20682751 | ||
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 5.35e-07 | 8 | 75 | 3 | 22262462 | |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 5.35e-07 | 8 | 75 | 3 | 21670213 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 5.35e-07 | 8 | 75 | 3 | 28745977 | |
| Pubmed | 5.35e-07 | 8 | 75 | 3 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 5.35e-07 | 8 | 75 | 3 | 21310149 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 8.02e-07 | 9 | 75 | 3 | 18394993 | |
| Pubmed | 8.02e-07 | 9 | 75 | 3 | 11553612 | ||
| Pubmed | 8.02e-07 | 9 | 75 | 3 | 10601307 | ||
| Pubmed | 8.02e-07 | 9 | 75 | 3 | 9733766 | ||
| Pubmed | 8.02e-07 | 9 | 75 | 3 | 28100513 | ||
| Pubmed | 8.02e-07 | 9 | 75 | 3 | 28877029 | ||
| Pubmed | 8.02e-07 | 9 | 75 | 3 | 17887960 | ||
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 1.03e-06 | 153 | 75 | 6 | 26365490 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 1.14e-06 | 10 | 75 | 3 | 8857542 | |
| Pubmed | 1.14e-06 | 10 | 75 | 3 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 1.14e-06 | 10 | 75 | 3 | 16332688 | |
| Pubmed | 1.14e-06 | 10 | 75 | 3 | 21859863 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 1.57e-06 | 11 | 75 | 3 | 35771867 | |
| Pubmed | 1.57e-06 | 11 | 75 | 3 | 17069463 | ||
| Pubmed | 1.57e-06 | 11 | 75 | 3 | 34110283 | ||
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 2.71e-06 | 13 | 75 | 3 | 31427429 | |
| Pubmed | 4.30e-06 | 15 | 75 | 3 | 14697343 | ||
| Pubmed | CLMP is a tumor suppressor that determines all-trans retinoic acid response in colorectal cancer. | 4.59e-06 | 2 | 75 | 2 | 37944525 | |
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 12351151 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 28490646 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 22765916 | ||
| Pubmed | Functional regulation of an outer retina hyporeflective band on optical coherence tomography images. | 4.59e-06 | 2 | 75 | 2 | 33986362 | |
| Pubmed | Nardilysin controls intestinal tumorigenesis through HDAC1/p53-dependent transcriptional regulation. | 4.59e-06 | 2 | 75 | 2 | 29669932 | |
| Pubmed | 7.35e-06 | 215 | 75 | 6 | 35973513 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 1.11e-05 | 231 | 75 | 6 | 16452087 | |
| Pubmed | Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. | 1.37e-05 | 3 | 75 | 2 | 28297668 | |
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 26398937 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 29875267 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 22374673 | ||
| Pubmed | 1.44e-05 | 22 | 75 | 3 | 27717094 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 1.66e-05 | 146 | 75 | 5 | 23892456 | |
| Pubmed | SRRT ZGPAT LSR MDN1 EIF4ENIF1 SUPT6H PPP1R9A RGPD3 ANKRD11 APC RPS17 DIDO1 DGCR8 | 1.74e-05 | 1497 | 75 | 13 | 31527615 | |
| Pubmed | 2.75e-05 | 4 | 75 | 2 | 22735794 | ||
| Pubmed | 2.75e-05 | 4 | 75 | 2 | 9480752 | ||
| Pubmed | Intestinal-specific activatable Myb initiates colon tumorigenesis in mice. | 2.75e-05 | 4 | 75 | 2 | 26300002 | |
| Pubmed | 4.57e-05 | 5 | 75 | 2 | 23390603 | ||
| Pubmed | 4.57e-05 | 5 | 75 | 2 | 26402607 | ||
| Pubmed | 4.57e-05 | 5 | 75 | 2 | 17557111 | ||
| Pubmed | 4.57e-05 | 5 | 75 | 2 | 9199196 | ||
| Pubmed | Celf4 controls mRNA translation underlying synaptic development in the prenatal mammalian neocortex. | 6.00e-05 | 35 | 75 | 3 | 37758766 | |
| Pubmed | 6.84e-05 | 6 | 75 | 2 | 20531296 | ||
| Pubmed | Genotype and phenotype of 101 dutch patients with congenital stationary night blindness. | 6.84e-05 | 6 | 75 | 2 | 23714322 | |
| Pubmed | 6.84e-05 | 6 | 75 | 2 | 28003334 | ||
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 7.70e-05 | 38 | 75 | 3 | 12791264 | |
| Pubmed | 7.79e-05 | 104 | 75 | 4 | 9205841 | ||
| Pubmed | 7.97e-05 | 329 | 75 | 6 | 17474147 | ||
| Pubmed | 8.10e-05 | 330 | 75 | 6 | 21044950 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | 9.37e-05 | 665 | 75 | 8 | 30457570 | |
| Pubmed | Nuclear PGK1 Alleviates ADP-Dependent Inhibition of CDC7 to Promote DNA Replication. | 9.57e-05 | 7 | 75 | 2 | 30392930 | |
| Pubmed | 9.57e-05 | 7 | 75 | 2 | 16059920 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 9.77e-05 | 861 | 75 | 9 | 36931259 | |
| Pubmed | 1.20e-04 | 689 | 75 | 8 | 36543142 | ||
| Pubmed | 1.27e-04 | 8 | 75 | 2 | 19805216 | ||
| Pubmed | 1.27e-04 | 8 | 75 | 2 | 27184122 | ||
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | 1.32e-04 | 226 | 75 | 5 | 37839992 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 1.32e-04 | 361 | 75 | 6 | 30344098 | |
| Pubmed | 1.64e-04 | 9 | 75 | 2 | 25049228 | ||
| Pubmed | 1.64e-04 | 9 | 75 | 2 | 21149733 | ||
| Pubmed | Interplay between cell-adhesion molecules governs synaptic wiring of cone photoreceptors. | 2.04e-04 | 10 | 75 | 2 | 32879010 | |
| Pubmed | 2.04e-04 | 10 | 75 | 2 | 10861224 | ||
| Pubmed | 2.04e-04 | 10 | 75 | 2 | 16902406 | ||
| Pubmed | 2.26e-04 | 963 | 75 | 9 | 28671696 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 2.30e-04 | 569 | 75 | 7 | 30639242 | |
| Pubmed | 2.49e-04 | 11 | 75 | 2 | 28262416 | ||
| Pubmed | 2.49e-04 | 11 | 75 | 2 | 30100344 | ||
| Pubmed | delta-Protocadherins: a gene family expressed differentially in the mouse brain. | 2.49e-04 | 11 | 75 | 2 | 15905963 | |
| Pubmed | RGPD4 MDN1 ANK2 RGPD8 CALD1 PCDHGA12 PPP1R9A RGPD3 RPS17 RIMS2 RGPD5 | 2.56e-04 | 1442 | 75 | 11 | 35575683 | |
| Pubmed | 2.99e-04 | 12 | 75 | 2 | 23793891 | ||
| Pubmed | A shared vesicular carrier allows synaptic corelease of GABA and glycine. | 2.99e-04 | 12 | 75 | 2 | 16701208 | |
| Pubmed | 2.99e-04 | 12 | 75 | 2 | 22474384 | ||
| Pubmed | TRIM28 protects TRIM24 from SPOP-mediated degradation and promotes prostate cancer progression. | 2.99e-04 | 12 | 75 | 2 | 30479348 | |
| Pubmed | 2.99e-04 | 12 | 75 | 2 | 22102170 | ||
| Pubmed | 2.99e-04 | 12 | 75 | 2 | 31296963 | ||
| Pubmed | Met signaling is required for recruitment of motor neurons to PEA3-positive motor pools. | 3.52e-04 | 13 | 75 | 2 | 12948444 | |
| Pubmed | Genome-wide association study of panic disorder in the Japanese population. | 3.52e-04 | 13 | 75 | 2 | 19165232 | |
| Pubmed | Protein interaction and cellular localization of human CDC45. | 3.52e-04 | 13 | 75 | 2 | 23364835 | |
| Interaction | RGPD4 interactions | 1.46e-08 | 22 | 74 | 5 | int:RGPD4 | |
| Interaction | RGPD2 interactions | 4.41e-08 | 27 | 74 | 5 | int:RGPD2 | |
| Interaction | RGPD3 interactions | 7.92e-07 | 47 | 74 | 5 | int:RGPD3 | |
| Interaction | RGPD1 interactions | 9.78e-07 | 49 | 74 | 5 | int:RGPD1 | |
| Interaction | RGPD8 interactions | 7.70e-06 | 74 | 74 | 5 | int:RGPD8 | |
| Interaction | RGPD5 interactions | 2.74e-05 | 96 | 74 | 5 | int:RGPD5 | |
| Cytoband | 2q13 | 1.94e-04 | 68 | 75 | 3 | 2q13 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.61e-05 | 115 | 50 | 5 | 769 | |
| GeneFamily | PDZ domain containing | 6.14e-05 | 152 | 50 | 5 | 1220 | |
| GeneFamily | CD molecules|Type II classical cadherins | 5.73e-04 | 13 | 50 | 2 | 1186 | |
| GeneFamily | Cadherin related | 9.93e-04 | 17 | 50 | 2 | 24 | |
| GeneFamily | Immunoglobulin like domain containing | 1.98e-03 | 193 | 50 | 4 | 594 | |
| GeneFamily | Zinc fingers CCCH-type | 4.21e-03 | 35 | 50 | 2 | 73 | |
| GeneFamily | MAGE family | 5.47e-03 | 40 | 50 | 2 | 1136 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 7.01e-06 | 43 | 75 | 4 | MM3857 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | 2.39e-08 | 181 | 75 | 7 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.58e-08 | 183 | 75 | 7 | 262387ee8d43b96e5f1a77c75124459a506a6172 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.58e-08 | 183 | 75 | 7 | c85a707acbcb582912e8ac080a36d05f91cfd7a2 | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(other)|Control / group, cell type (main and fine annotations) | 2.88e-08 | 186 | 75 | 7 | c6075fe84226b370c5139066793844ad33ae2db1 | |
| ToppCell | Control-Endothelial_cells|Control / group, cell type (main and fine annotations) | 3.10e-08 | 188 | 75 | 7 | 3953b08abfea93468fc8d177bdb16ca7c6ffa1ab | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.72e-08 | 193 | 75 | 7 | f582e939e3e08a8a3f71deec78c33715be8faa51 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.13e-08 | 196 | 75 | 7 | 686533fd3fba8e4df96b9dd1307e870e89db4332 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.71e-07 | 157 | 75 | 6 | 275a4c6fef1fff8da2bdc48e3924ad05c5e5cfc8 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 7.32e-07 | 186 | 75 | 6 | 5cadab3271fce9ab6da3d7ba9827b8a221cac166 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.55e-07 | 187 | 75 | 6 | 35c382c0aabd46906113e5db30ea24bb8e658899 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175|Adult / Lineage, Cell type, age group and donor | 7.55e-07 | 187 | 75 | 6 | f3548817f2fded5978137bb252cb628ac199e4f6 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D122|Adult / Lineage, Cell type, age group and donor | 7.79e-07 | 188 | 75 | 6 | 02a62888e9db29d20133eeca1686d302545a39c9 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 8.28e-07 | 190 | 75 | 6 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 8.28e-07 | 190 | 75 | 6 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 8.54e-07 | 191 | 75 | 6 | c672c8e28d06d555335976b3f8bd2ea6d3b34aae | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Control / Disease state, Lineage and Cell class | 8.54e-07 | 191 | 75 | 6 | 322237793a1278bafb14e63cab688b353e352dcc | |
| ToppCell | droplet-Kidney-nan-18m-Endothelial-kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.80e-07 | 192 | 75 | 6 | 144503af50274eaed5cf6effa892c640eab28663 | |
| ToppCell | droplet-Kidney-nan-18m-Endothelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.80e-07 | 192 | 75 | 6 | c96736bb3a6bb052678b1b078f7823063ca69e6d | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.08e-07 | 193 | 75 | 6 | 9ba688b35a9ead5d04691b3f3f15484f02dbbd0d | |
| ToppCell | COPD-Endothelial|COPD / Disease state, Lineage and Cell class | 9.08e-07 | 193 | 75 | 6 | 093b28dcccb5841c995d0b33fae0efd6b88f97e0 | |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 9.08e-07 | 193 | 75 | 6 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|IPF / Disease state, Lineage and Cell class | 9.35e-07 | 194 | 75 | 6 | 169a304d5c13f08c39fad4116f093bc4a0765e9d | |
| ToppCell | IPF-Endothelial|IPF / Disease state, Lineage and Cell class | 9.35e-07 | 194 | 75 | 6 | 9591993aa2dcba3d09a0f1ea8b8f2439c26482d6 | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|COPD / Disease state, Lineage and Cell class | 9.35e-07 | 194 | 75 | 6 | 18b7f901c12ca4f21f9a1eafd092aefe4d668b6d | |
| ToppCell | Adult-Endothelial|Adult / Lineage, Cell type, age group and donor | 9.35e-07 | 194 | 75 | 6 | 963b3fbee0575af8379baa397ace65949eaf34f7 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 9.64e-07 | 195 | 75 | 6 | 120296531bbc8080dcabacbd64733cc1dc34603a | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.64e-07 | 195 | 75 | 6 | fde8e7b38b3631109b95ef111c5f6e3f9878cfbd | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|IPF / Disease state, Lineage and Cell class | 9.64e-07 | 195 | 75 | 6 | 2c3ad3cb79f11119ac69c413a938d21199145040 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.64e-07 | 195 | 75 | 6 | 023e3c97dd3696d74f002ff8da0c04d876c82aef | |
| ToppCell | Children_(3_yrs)-Endothelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.64e-07 | 195 | 75 | 6 | 094cf6591daa5ffad36e44122b6f524a3a34c2fd | |
| ToppCell | Endothelial|World / Lineage, Cell type, age group and donor | 9.93e-07 | 196 | 75 | 6 | 96c6d78482a130ce4e29f6629972a06d10d7530e | |
| ToppCell | nucseq-Endothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.02e-06 | 197 | 75 | 6 | ebf9be068eaa658493fa7884fd19f34642922acb | |
| ToppCell | Parenchymal-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-06 | 199 | 75 | 6 | a4a9a1c2a34b5a8318a55d1211d6c8661ca9793e | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122|Adult / Lineage, Cell type, age group and donor | 1.04e-05 | 171 | 75 | 5 | bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc | |
| ToppCell | Control-Endothelial_cells-Systemic_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 1.07e-05 | 172 | 75 | 5 | c55dce1ed3ed7312394b4e050e1de852a994e130 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-05 | 174 | 75 | 5 | c988471207ba06195bc3e41056435e8c31c20bbe | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.20e-05 | 176 | 75 | 5 | 269326c2bf44a9003d95bc6dbc839f08f25737ca | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.23e-05 | 177 | 75 | 5 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-D|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-05 | 177 | 75 | 5 | a0b172f40e0df97a288a5549ae7066697ad469b3 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.23e-05 | 177 | 75 | 5 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 1.23e-05 | 177 | 75 | 5 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.23e-05 | 177 | 75 | 5 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.23e-05 | 177 | 75 | 5 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.23e-05 | 177 | 75 | 5 | 0e74980a7686c31fcf1476b8f19a3392541df240 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-D-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-05 | 177 | 75 | 5 | ab8f09e118e4df696b0b4d33f013da020bdbd351 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_proliferating_1|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-05 | 179 | 75 | 5 | ec69e1dd897414033ba5b007aa82655a79adca6c | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.30e-05 | 179 | 75 | 5 | ff678e2f33c914e3dd0f338ada25f506c3e3c980 | |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | 1.33e-05 | 180 | 75 | 5 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.41e-05 | 182 | 75 | 5 | a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-05 | 184 | 75 | 5 | 688428103e8b19f45f2f65d70a0f30c904c8411c | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.48e-05 | 184 | 75 | 5 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 1.52e-05 | 185 | 75 | 5 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 1.52e-05 | 185 | 75 | 5 | 4abe04198ab5047c211f8d09cdb9650fa52a3cd6 | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.52e-05 | 185 | 75 | 5 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|COPD / Disease state, Lineage and Cell class | 1.56e-05 | 186 | 75 | 5 | 23c7d0e8372a71546d687278b985f761d282f92f | |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.60e-05 | 187 | 75 | 5 | 2d20193a6cacdfa4877457c97b0077408942186c | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(general)|Control / group, cell type (main and fine annotations) | 1.60e-05 | 187 | 75 | 5 | fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 187 | 75 | 5 | e93cad16a087d1443cbf4e1690dc1b35d7a84c41 | |
| ToppCell | Control-Endothelial-VE_Peribronchial|Control / Disease state, Lineage and Cell class | 1.64e-05 | 188 | 75 | 5 | f5b7dbc89f992c13280d36a34935be83906b1bc0 | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 1.64e-05 | 188 | 75 | 5 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.64e-05 | 188 | 75 | 5 | fe7143c36e4a883745862d3c3147cf751b440e46 | |
| ToppCell | Endothelial-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.64e-05 | 188 | 75 | 5 | 0824d567356d360fd8e78e840c30529c139f98a1 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.64e-05 | 188 | 75 | 5 | cbf32b675a7cd0c808d5c9c22dfa7fa79fbe2437 | |
| ToppCell | Control-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 1.69e-05 | 189 | 75 | 5 | c76d8af2e0aa4a83ee0c3439c894566fbf117dd3 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.69e-05 | 189 | 75 | 5 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.73e-05 | 190 | 75 | 5 | f6c38d197fd9d69a4f97cb2e72cd4747984c1a86 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.77e-05 | 191 | 75 | 5 | dc9e5eb6aa31b8d79aeec33e59b9138dfb469a3b | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-SVEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.82e-05 | 192 | 75 | 5 | c3dda7c48732b0b8bde36de282d64192f5e9b98f | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.87e-05 | 193 | 75 | 5 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | COPD-Endothelial-VE_Arterial|COPD / Disease state, Lineage and Cell class | 1.87e-05 | 193 | 75 | 5 | 1c701b6ab5f0f0239634adac94fa1c92bf3c36f4 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.87e-05 | 193 | 75 | 5 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.87e-05 | 193 | 75 | 5 | f27e2be497745098b5269aa799dd3d5f62d78ba7 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.87e-05 | 193 | 75 | 5 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | IPF-Endothelial-VE_Arterial|IPF / Disease state, Lineage and Cell class | 1.87e-05 | 193 | 75 | 5 | bf83b1fe9d38408f30eee4eb634341c04ef82791 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)|Adult / Lineage, Cell type, age group and donor | 1.87e-05 | 193 | 75 | 5 | 39c6c96a2a100b1b290a779d36cc6bc17245720b | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 1.87e-05 | 193 | 75 | 5 | d7750a7575ef257963b7f1c64fa67c52dbff797b | |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.87e-05 | 193 | 75 | 5 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.87e-05 | 193 | 75 | 5 | c0973a2c97deb7176c2f617c8760a55f7edc9839 | |
| ToppCell | IPF-Endothelial-VE_Venous|IPF / Disease state, Lineage and Cell class | 1.87e-05 | 193 | 75 | 5 | 29a655fa80feaabe846c90a28363b037e22d24ae | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.87e-05 | 193 | 75 | 5 | ad3f4fcc8e2816d696cbcde744dc16500e51ccac | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.87e-05 | 193 | 75 | 5 | 4ccf984baebbb13ae916727137ce593fda7514a2 | |
| ToppCell | IPF-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 1.87e-05 | 193 | 75 | 5 | ef66a46e7ab44fcc4005a23416e6da478a4cce37 | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 1.91e-05 | 194 | 75 | 5 | 68705a6eca947c5b42b943d5224a7aef2a744007 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.91e-05 | 194 | 75 | 5 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | Control-Endothelial|Control / Disease state, Lineage and Cell class | 1.91e-05 | 194 | 75 | 5 | 485fe5538fabec457b9a51feb641f2a91cbf4e18 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.96e-05 | 195 | 75 | 5 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.96e-05 | 195 | 75 | 5 | 19347b7e8d3ea67e0fddd948078abcab9d364a2d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-05 | 195 | 75 | 5 | 818bc18c5834238e5f733cac6fe928ed0788f57d | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.96e-05 | 195 | 75 | 5 | 55b4030f078173b0136990fae87b6eaf44c58f33 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-endo_capillary_(2)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.01e-05 | 196 | 75 | 5 | 2a2a93b89dcb98043cb1f8b422ac8c55e2edc37b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-05 | 196 | 75 | 5 | 7cbb19108b4553ef60ef5c230a29de1662c02efe | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-05 | 196 | 75 | 5 | 4cd1e6b7a791e11a40b19f971b7011bd11fe6273 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-05 | 196 | 75 | 5 | d37f714d4fb57e958f3738fdda085560813e5bb5 | |
| ToppCell | Fetal_29-31_weeks-Endothelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.01e-05 | 196 | 75 | 5 | 3981f6c7487598f4f7ce4650ac0ac5bd41481d66 | |
| ToppCell | Endothelial-capillary_endothelial_cell_(Cap1)|World / Lineage, Cell type, age group and donor | 2.01e-05 | 196 | 75 | 5 | 0ce3ed27d2b9276390952652c17a8d6de13add36 | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Endothelial-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.06e-05 | 197 | 75 | 5 | f969685dee212f33a6f09e54c0cd1fd24ffef546 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-05 | 197 | 75 | 5 | 0f467ef58f0c4dcc00b34b7b9639e03fb3ebe780 | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 2.06e-05 | 197 | 75 | 5 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-05 | 197 | 75 | 5 | b0036cf3f7e6edf8e43f16cd2f0f0e80471d2576 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_capillary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-05 | 197 | 75 | 5 | 81718164c9802ee20c860ffbda7e62d5e9a76f16 | |
| Drug | Proxyphylline [603-00-9]; Up 200; 16.8uM; MCF7; HT_HG-U133A | 4.07e-06 | 198 | 75 | 7 | 5993_UP | |
| Disease | Congenital stationary night blindness | 3.41e-05 | 4 | 71 | 2 | cv:C0339535 | |
| Disease | Glioblastoma | 4.03e-05 | 79 | 71 | 4 | C0017636 | |
| Disease | Giant Cell Glioblastoma | 5.13e-05 | 84 | 71 | 4 | C0334588 | |
| Disease | Cleft palate, cleft lip, alcohol exposure measurement, parental genotype effect measurement | 5.68e-05 | 5 | 71 | 2 | EFO_0003959, EFO_0005939, EFO_0009113, HP_0000175 | |
| Disease | Glioblastoma Multiforme | 1.52e-04 | 111 | 71 | 4 | C1621958 | |
| Disease | Respiratory Distress Syndrome, Adult | 3.20e-04 | 55 | 71 | 3 | C0035222 | |
| Disease | X-Linked Csnb | 3.71e-04 | 12 | 71 | 2 | C3711543 | |
| Disease | Night blindness, congenital stationary, type 1 | 3.71e-04 | 12 | 71 | 2 | C3501847 | |
| Disease | Night Blindness, Congenital Stationary, Type 1A | 3.71e-04 | 12 | 71 | 2 | C3495587 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder) | 3.71e-04 | 12 | 71 | 2 | C1864877 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A | 3.71e-04 | 12 | 71 | 2 | C1848172 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B | 3.71e-04 | 12 | 71 | 2 | C1850362 | |
| Disease | Cone-rod synaptic disorder, congenital nonprogressive | 4.38e-04 | 13 | 71 | 2 | C4041558 | |
| Disease | chromosome 22q11.2 deletion syndrome, distal (implicated_via_orthology) | 5.10e-04 | 14 | 71 | 2 | DOID:0060413 (implicated_via_orthology) | |
| Disease | Night blindness, congenital stationary | 7.58e-04 | 17 | 71 | 2 | C0339535 | |
| Disease | food allergy measurement, parental genotype effect measurement | 8.52e-04 | 18 | 71 | 2 | EFO_0005939, EFO_0007016 | |
| Disease | phosphatidylinositol measurement | 1.58e-03 | 95 | 71 | 3 | EFO_0010230 | |
| Disease | fat body mass | 1.88e-03 | 217 | 71 | 4 | EFO_0005409 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EERERRDNYVPEVSA | 76 | P08708 | |
| EAIYDDVPRENSDSE | 236 | O15013 | |
| DDQRPENYREALGDV | 406 | P06276 | |
| EYEFDEDDEQDRVPP | 346 | Q6UB99 | |
| RAEDILPTYDQEDRE | 141 | Q9BWW8 | |
| RTSYREEEPAEFQID | 386 | O00178 | |
| ERYDEEEEAERDRLN | 666 | P54840 | |
| DDPNERESDRVYLDL | 526 | Q8N4X5 | |
| EEEEERAQEHSRPEY | 476 | Q9NQ90 | |
| QRDRVDEEALNFPYE | 226 | Q8WYQ5 | |
| RRDPQDDVYVDITDR | 11 | A4D256 | |
| TDRPLDRETQDEYNV | 426 | O14917 | |
| DVQEPELEDLARYDV | 411 | Q99666 | |
| DVQEPELEDLARYDV | 411 | O14715 | |
| VEVRDINDNAPYFRE | 121 | O60330 | |
| DVLEVCDDYDRERNE | 46 | Q8TAE7 | |
| LYDSDEEDEERPARK | 136 | P49736 | |
| DPQDEQERIEERLAY | 3561 | Q01484 | |
| QDEDEEVPDRLSYLD | 1746 | O60840 | |
| ELDRDPAYAIVTVDD | 266 | Q14517 | |
| RAEESIEDIYANIPD | 131 | Q9NP74 | |
| EQIDERDYDENEVDP | 4851 | Q9NU22 | |
| YEEALQDEEESPSQR | 236 | Q9BZ81 | |
| PEQYREAVEDEEARA | 496 | Q8TD90 | |
| RNPYLLSEEEDDDVD | 411 | O60524 | |
| LSREREEEDDYRQEE | 291 | Q99795 | |
| EELTDPENRRRYEAE | 41 | Q9NVR5 | |
| PEEDETDDRRRRYNS | 231 | Q96BZ8 | |
| YIPEEENENLEASRE | 3391 | Q5CZC0 | |
| GPQEADRLDELEYEE | 116 | Q76G19 | |
| RPIEDDQEVYDDVAE | 586 | O15117 | |
| RDPSNQEDVEAARRY | 1606 | P09848 | |
| DEEAREELREQVYDA | 136 | P49321 | |
| VSQDIDRERDPATYD | 726 | Q6V1P9 | |
| DDEDVESRDEYERQR | 341 | Q9UQ26 | |
| DVQEPELEDLARYDV | 411 | A6NKT7 | |
| EVPAYEDIFRDEEED | 126 | O75419 | |
| APDADEEQRYQAFRE | 941 | A4D2P6 | |
| DYEEQRTVDPEQARG | 726 | O15303 | |
| AVDEVLDEAVPEYRA | 36 | Q99819 | |
| AAAAEREEVAYDPED | 1416 | Q9BTC0 | |
| RDGYDAERAQDPEDE | 101 | Q02410 | |
| AERAQDPEDESAYAV | 106 | Q02410 | |
| EDDEENYENVPRVLL | 716 | Q96P31 | |
| DDEDVRENIIRYDDE | 656 | P55286 | |
| DEERDIRENIVRYDD | 641 | Q9ULB5 | |
| NERHRYDDVEYEEEP | 241 | Q8N4B5 | |
| PAEEEEDELYRQSLE | 166 | Q07820 | |
| EERRRPHKEEEEEAY | 601 | Q86X29 | |
| LEEERATYPQEEDRF | 166 | Q0VD86 | |
| DPELEVEYRESRESD | 1506 | Q5T011 | |
| DVQEPELEDLARYDV | 411 | Q7Z3J3 | |
| SIPEYTAEEEREDNR | 2866 | Q8WUY3 | |
| RFERRTDIPEAEDVY | 396 | Q8N135 | |
| DVAGNPEEERRAEFY | 436 | Q6STE5 | |
| EEAREVFENDPETDY | 66 | P07225 | |
| IVEYRDLDAPDDVDF | 861 | Q9BXP5 | |
| GERRRNDSYTEEEPE | 206 | Q9NRA8 | |
| EAERIAYQRNDDDEE | 21 | Q05682 | |
| RYSEEEQHEEEERPT | 1146 | P25054 | |
| KERYEEEERPNEIRE | 261 | Q9H6B4 | |
| EYEDDEAEGEIRVRP | 241 | Q7KZ85 | |
| REVEAVDSEYQLARP | 306 | O43847 | |
| DLDDEDYEEDTPKRR | 166 | Q92785 | |
| LVQRYAEDLDQPERD | 1126 | O94885 | |
| LYENDTDEPREEEVE | 291 | Q5VVX9 | |
| RDPGSEIEDRQYQID | 1616 | Q7Z7G8 | |
| YEENEDGEVVRVRDS | 171 | Q9H598 | |
| RRSPQENEDDEDDYQ | 546 | Q9ULL1 | |
| AEERRRVENIEPFDE | 281 | O60294 | |
| LDEERPGRQEDAEYQ | 66 | Q8N5A5 | |
| ARDNEAFEVPVYEEA | 81 | Q8IV31 | |
| LDLSAYERPEEDENE | 301 | Q562E7 | |
| YERPEEDENEEAPVA | 306 | Q562E7 | |
| RELDEHELDYDEEVP | 121 | Q86VM9 | |
| PEDSEVPFTEEDYRR | 166 | Q96M32 | |
| SNEDYDRRNDEVDPV | 471 | Q9ULJ8 |